Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Thyroid-stimulating Immunoglobulins Level in Patients With Graves' Disease Undergoing Maintenance-dose of Antithyroid Drug and Its Relationship With Disease Relapse

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05713097
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:20.121315+00:00
Published At
2023-02-06T00:00:00+00:00
Record Updated At
2023-02-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Graves Disease", "Immunoglobulin", "Anti-Thyroid Antibodies Disorder"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-02-06"
protocolSection.identificationModule.nctId
"NCT05713097"
protocolSection.identificationModule.officialTitle
"Thyroid-stimulating Immunoglobulins Level in Patients With Graves\u0027 Disease Undergoing Maintenance-dose of Antithyroid Drug and Its Relationship With Disease Relapse"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Graves Disease (protocolSection.conditionsModule.conditions)
  • Immunoglobulin (protocolSection.conditionsModule.conditions)
  • Anti-Thyroid Antibodies Disorder (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.